← Back to Search

Behavioral Intervention

We Walk Plus Program for Older Adults with Intellectual Disabilities

N/A

Recruiting

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ages 35-60

Able to follow instructions and walk, physically inactive

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial will test a new program to see if it helps promote physical activity and improve cognition for older adults with intellectual disabilities.

Who is the study for?

This trial is for men and women aged 35-60 with mild or moderate intellectual disabilities. Participants must speak English, consent to enroll, be willing to receive SMS, wear a Fitbit during the study, live with family or in community housing, and have support persons to help with the device. They should be physically inactive but able to walk and follow instructions.Check my eligibility

What is being tested?

The We Walk Plus Study tests an intervention designed to encourage physical activity and enhance cognitive function in older adults with intellectual disabilities. It involves using a Fitbit and receiving SMS messages as part of the program.See study design

What are the potential side effects?

Since this is not a drug trial but an exercise-based intervention involving wearing a Fitbit and receiving text messages, there are no direct medical side effects expected from participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 35 and 60 years old.

Select...

I can walk and follow instructions but I am not physically active.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Physical activity

Secondary outcome measures

Attention & executive function

Cardiovascular fitness

Executive function

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: We Walk Plus InterventionExperimental Treatment1 Intervention

The intervention group will receive a Fitbit, SMS and will be assigned to a private Fitbit community (4-5 participants per group) for 12 weeks. During the intervention, participants will receive weekly personalized SMS on their mobile phones including encouraging messages, reminders, and tips to increase steps, and weekly step goals. The investigators will use a secure, web-based platform, iCardia, to support continuous real-time remote monitoring of activity data from Fitbit devices and personalized communication via SMS based on incoming data. The investigators will set up the Fitbit networking settings on participants' phones to give notifications when there are posts to this group. Individual goals and a weekly team goal of steps will be set up by the research team. Each member will be awarded a badge upon reaching each individual's weekly goal. Teams will also be awarded badges when all team members reach their individual weekly goals.

Group II: Attention control groupActive Control1 Intervention

The attention control group will also receive a Fitbit and will be asked to continue with normal daily activities. During the initial in-person session, they will receive the same PA recommendations as the intervention group to walk at least 30 minutes for 5 days or more a week or 10,000 steps a day. However, a plan for improving PA will not be discussed.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor

608 Previous Clinical Trials

1,559,459 Total Patients Enrolled

Media Library

We Walk Plus Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04573530 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor admit participants under the age of fifty-five?

"This clinical trial is open to participants aged 35 and older, but below the age of 60."

Answered by AI

What is the greatest number of participants taking part in this experiment?

"Affirmative. Data accessible from clinicaltrials.gov verifies that this medical research, which was initially put online on June 15th 2021, is currently searching for participants. Approximately 46 patients must be recruited between two distinct sites."

Answered by AI

Is this research currently recruiting participants?

"Data posted on clinicaltrials.gov confirms that this medical trial is currently accepting patients. The study was first released to the public on June 15th 2021 and the latest update was made on June 21st 2022."

Answered by AI

Who is eligible for enrollment in this research trial?

"This research project requires 46 individuals, aged 35-60 and with a diagnosis of mental retardation. Qualified participants must be conversant in English and provide informed consent; able to comprehend instructions and ambulate; inactive physically; agree to receive text messages on their phones as well as wear a Fitbit for the duration of the study period; have family or reside in supported living quarters that are willing to assist with any technical issues regarding their Fitbits."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

We Walk Plus Study for Older Adults With Intellectual Disabilities

Kueifang Hsieh 2021. "We Walk Plus Study for Older Adults With Intellectual Disabilities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04573530.